S123: ACUTE MYELOID LEUKEMIA STEM CELL SUBTYPES DEFINED BY MUTATIONS AND DIFFERENTIATION STATE REGULATE APOPTOTIC DEPENDENCY AND CLINICAL RESPONSE TO VENETOCLAX.

• Alexander Waclawiczek,
• Aino-Maija Leppä,
• Simon Renders,
• Barbara Betz,
• Karolin Stumpf,
• Maike Jansen,
• Anne Kathrin Merbach,
• Rabia Shahswar,
• Christoph Röllig,
• Michael Heuser,
• Tim Sauer,
• Carsten Müller-Tidow,
• Andreas Trumpp

Affiliations

Alexander Waclawiczek

1 German Cancer Research Center, Heidelberg, Germany

Aino-Maija Leppä

1 German Cancer Research Center, Heidelberg, Germany

Simon Renders

1 German Cancer Research Center, Heidelberg, Germany

Barbara Betz

1 German Cancer Research Center, Heidelberg, Germany

Karolin Stumpf

1 German Cancer Research Center, Heidelberg, Germany

Maike Jansen

3 Heidelberg University Hospital, Department of Internal Medicine V, Heidelberg, Germany

Anne Kathrin Merbach

3 Heidelberg University Hospital, Department of Internal Medicine V, Heidelberg, Germany

Rabia Shahswar

5 Hannover Medical School, Department of Hematology, Hannover, Germany

Christoph Röllig

6 Universitätsklinikum der Technischen Universität Dresden, Medizinische Klinik und Poliklinik I, Dresden, Germany

Michael Heuser

5 Hannover Medical School, Department of Hematology, Hannover, Germany

Tim Sauer

3 Heidelberg University Hospital, Department of Internal Medicine V, Heidelberg, Germany

Carsten Müller-Tidow

3 Heidelberg University Hospital, Department of Internal Medicine V, Heidelberg, Germany

Andreas Trumpp

1 German Cancer Research Center, Heidelberg, Germany